University Hospital Plymouth NHS Trust   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Plymouth United Kingdom (1948)

Organization Overview

First Clinical Trial
2017
NCT03307746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

University Hospital Plymouth NHS Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Carpal Tunnel Syndrome (Phase 3)

Cerebral Hemorrhage (Phase 3)

Depression (Phase 3)

Depressive Disorder (Phase 3)

De Quervain Disease (Phase 3)

Hemorrhage (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Parkinson Disease (Phase 3)

Tenosynovitis (Phase 3)

Trigger Finger Disorder (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 10